Development of Covalent Ligand-Receptor Pairs to Study the Binding Properties of Nonpeptidic Neurotensin Receptor 1 Antagonists.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  ACS Chemical Biology

• Publication date

  2016-01-27

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1021/acschembio.5b00965PMID 26808719
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• In Silico Investigation of the Neurotensin Receptor 1 Binding Site: Overlapping Binding Modes for Small Molecule Antagonists and the Endogenous Peptide Agonist

  2016cited by this paper
• Structural prerequisites for G-protein activation by the neurotensin receptor

  2015cited by this paper
• GPCR crystal structures: Medicinal chemistry in the pocket.

  2015cited by this paper
• Covalent molecular probes for class A G protein-coupled receptors: advances and applications.

  2015cited by this paper
• Methodological advances: the unsung heroes of the GPCR structural revolution

  2015cited by this paper
• Covalent agonists for studying G protein-coupled receptor activation

  2014cited by this paper
• Structure of signaling-competent neurotensin receptor 1 obtained by directed evolution in Escherichia coli

  2014cited by this paper
• In Vivo Monitoring of the Antiangiogenic Effect of Neurotensin Receptor-Mediated Radiotherapy by Small-Animal Positron Emission Tomography: A Pilot Study

  2014cited by this paper
• Structure-Based Evolution of Subtype-Selective Neurotensin Receptor Ligands

  2014cited by this paper
• Functionally selective dopamine D₂, D₃ receptor partial agonists.

  2014cited by this paper
• The structural basis of G-protein-coupled receptor signaling (Nobel Lecture).

  2013cited by this paper
• Synthesis and evaluation of a (18)F-labeled diarylpyrazole glycoconjugate for the imaging of NTS1-positive tumors.

  2013cited by this paper
• Structural basis for modulation of a G-protein-coupled receptor by allosteric drugs

  2013cited by this paper
• Efficient Synthesis of Heterocyclic Neurotensin Receptor Ligands by Microwave-Assisted Aminocarbonylation

  2013cited by this paper
• Structure-based drug screening for G-protein-coupled receptors.

  2012cited by this paper
• Structure of the agonist-bound neurotensin receptor

  2012cited by this paper
• LigPlot+: Multiple Ligand-Protein Interaction Diagrams for Drug Discovery

  2011cited by this paper
• Cross-receptor interactions between dopamine D2L and neurotensin NTS1 receptors modulate binding affinities of dopaminergics.

  2011cited by this paper
• Discovery of highly potent and neurotensin receptor 2 selective neurotensin mimetics.

  2011cited by this paper
• Pathway and mechanism of drug binding to G-protein-coupled receptors

  2011cited by this paper
• Rapid release of entrapped contents from multi-functionalizable, surface cross-linked micelles upon different stimulation.

  2010cited by this paper
• Structure and Function of an Irreversible Agonist-β2 Adrenoceptor complex

  2010cited by this paper
• Dopamine D2, D3, and D4 selective phenylpiperazines as molecular probes to explore the origins of subtype specific receptor binding.

  2009cited by this paper
• GROMACS 4:  Algorithms for Highly Efficient, Load-Balanced, and Scalable Molecular Simulation.

  2008cited by this paper
• Novel insights into GPCR-peptide interactions: mutations in extracellular loop 1, ligand backbone methylations and molecular modeling of neurotensin receptor 1.

  2008cited by this paper
• Prediction of protein-ligand interactions. Docking and scoring: successes and gaps.

  2006cited by this paper
• Comparison of multiple Amber force fields and development of improved protein backbone parameters

  2006cited by this paper
• Disulfide trapping to localize small-molecule agonists and antagonists for a G protein-coupled receptor.

  2005cited by this paper
• 1,3-Dibromo-5,5-Dimethylhydantoin [DBDMH] as an Efficient and Selective Agent for the Oxidation of Thiols to Disulfides in Solution or under Solvent-Free Conditions

  2004cited by this paper
• Development and testing of a general amber force field

  2004cited by this paper
• UCSF Chimera—A visualization system for exploratory research and analysis

  2004cited by this paper
• Tethering: fragment-based drug discovery.

  2004cited by this paper
• The PyMOL Molecular Graphics System

  2002cited by this paper
• Target validation of G-protein coupled receptors.

  2002cited by this paper
• Impaired G protein coupling of the neurotensin receptor 1 by mutations in extracellular loop 3.

  2001cited by this paper
• Neurotensin and dopamine interactions.

  2001cited by this paper
• Conjugated enynes as nonaromatic catechol bioisosteres: synthesis, binding experiments, and computational studies of novel dopamine receptor agonists recognizing preferentially the D(3) subtype.

  2000cited by this paper
• Does neurotensin mediate the effects of antipsychotic drugs?

  1999cited by this paper
• Mutagenesis and Modeling of the Neurotensin Receptor NTR1

  1998cited by this paper
• A well-behaved electrostatic potential-based method using charge restraints for deriving atomic char

  1993cited by this paper
• Biochemical and pharmacological profile of a potent and selective nonpeptide antagonist of the neurotensin receptor.

  1993cited by this paper
• Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction.

  1973cited by this paper
• Protein measurement with the Folin phenol reagent.

  1951cited by this paper
• AN EFFICIENT SYNTHESIS

  year unknowncited by this paper

• 99mTc-Labeled Diarylpyrazoles for Single-Emission Computer Tomography Imaging of Neurotensin Receptor-Positive Tumors: A Comparative Preclinical Study

  2025cites this paper
• Ligands selectively tune the local and global motions of neurotensin receptor 1 (NTS1)

  2023cites this paper
• Development of Photoswitchable Tethered Ligands that Target the μ‐Opioid Receptor

  2023cites this paper
• Development of disulfide-functionalized peptides covalently binding G protein-coupled receptors.

  2022cites this paper
• Ligands tune the local and global motions of neurotensin receptor 1 (NTS1): a DFT-guided solution NMR analysis

  2022cites this paper
• Complexes of the neurotensin receptor 1 with small-molecule ligands reveal structural determinants of full, partial, and inverse agonism

  2021cites this paper
• Structure Determination of Inactive-State GPCRs with a Universal Nanobody

  2021cites this paper
• Effect of thermostable mutations on the neurotensin receptor 1 (NTSR1) activation state

  2020cites this paper
• Covalent Inhibition of the Histamine H3 Receptor

  2019cites this paper
• Development of covalent antagonists for β1- and β2-adrenergic receptors.

  2019cites this paper
• Covalent Allosteric Probe for the Metabotropic Glutamate Receptor 2: Design, Synthesis, and Pharmacological Characterization

  2018cites this paper
• A split luciferase-based probe for quantitative proximal determination of Gαq signalling in live cells

  2018cites this paper
• Computational investigation of the conformational dynamics in Tom20‐mitochondrial presequence tethered complexes

  2018cites this paper
• Potent haloperidol derivatives covalently binding to the dopamine D2 receptor.

  2017cites this paper
• En route towards the peptide γ‐helix: X‐ray diffraction analyses and conformational energy calculations of Adm‐rich short peptides

  2017cites this paper
• Ligand Discovery for a Peptide-Binding GPCR by Structure-Based Screening of Fragment- and Lead-Like Chemical Libraries.

  2017cites this paper
• Tethering an N-Glycosylation Sequon-Containing Peptide Creates a Catalytically Competent Oligosaccharyltransferase Complex.

  2017cites this paper
• NTS2-selective neurotensin mimetics with tetrahydrofuran amino acids.

  2017cites this paper